ヘルスケアにおけるメタバース市場：コンポーネント（ハードウェア、サービス、ソフトウェア）、テクノロジー（AR/VR、MR、AI、ブロックチェーン、IoT）、アプリケーション（テレヘルス、診断、医療トレーニング＆教育）、エンドユーザー（プロバイダー、患者、ペイヤー、ファーマ）別 - 2028年までの世界予測

Metaverse in Healthcare Market by Component (Hardware, Services, Software), Technology (AR/VR, MR, AI, Blockchain, IoT), Application(Telehealth, Diagnostics, Medical Training & Education), End User (Provider, Patients, Payers, Pharma) - Global Forecast to 2028

世界のメタバース・イン・ヘルスケア市場は、2023年の95億米ドルから2028年には796億米ドルに達すると予測され、予測期間中のCAGRは52.9%に達すると予測されています。北米では、ヘルスケア向けのメタバース技術... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2023年5月9日	US$4,950 シングルユーザライセンスライセンス・価格情報注文方法はこちら	233	160	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

世界のメタバース・イン・ヘルスケア市場は、2023年の95億米ドルから2028年には796億米ドルに達すると予測され、予測期間中のCAGRは52.9%に達すると予測されています。北米では、ヘルスケア向けのメタバース技術への傾倒が進んでいます。手術トレーニング、疼痛管理、治療など、さまざまなヘルスケアアプリケーションで使用されている仮想現実および拡張現実（VR/AR）技術の人気が高まっていることが、この地域の市場成長の要因となっています。また、COVID-19の流行により、遠隔医療サービスの導入が加速し、患者や医療従事者にとって、より没入感のある魅力的な仮想体験の必要性が高まっています。メタバースは、現実のやり取りをシミュレートした仮想環境を提供することができ、患者と医療従事者がより自然で直感的な方法でコミュニケーションやコラボレーションを行うことを可能にします。

"ヘルスケアにおけるメタバース市場において、ソフトウェアセグメントが最大のセグメントとなると予測されている"。
構成要素に基づくと、予測期間中、ソフトウェアセグメントが最大のセグメントになると予測されています。このシェアは、カスタマイズやパーソナライゼーションの可能性などの要因に起因しています。医療従事者や患者は、ソフトウェアを使用して、特定のニーズ、好み、および病状に合わせた仮想環境を作成し、アクセスすることができ、より高い精度と柔軟性のために複雑な外科手術を行うためのARプラットフォームの適応が増加しており、ソフトウェアセグメントへの投資が行われています。

"2022年のヘルスケア市場におけるメタバースのエンドユーザー別セグメントでは、ヘルスケアプロバイダーが最大となった"。
2022年のメタバース・イン・ヘルスケア市場では、ヘルスケアプロバイダーが最も高い成長率で成長すると予測されています。この高い成長は、効率的なヘルスケアシステムへのニーズの高まり、患者数の増加、病院や外来診療センターの増加、テレヘルスの成長、ヘルスケアにおけるメタバース技術の採用率の上昇に起因していると考えられます。

"予測期間中、APACが最も高い成長率を目撃する"
アジア太平洋地域は、予測期間中、最も高いCAGRで成長すると予測されています。APAC地域の市場成長は、主に医療観光産業の成長、ライフスタイルや慢性疾患の発生率の増加、メタバース技術の採用の高まりに起因する要因によってもたらされます。アジア太平洋地域は、主に政府の取り組みや生活習慣病の増加により、市場関係者にとって有利な成長機会を提供しています。これらの市場の成長は、おそらく中国、韓国、日本が中心となっています。これは主に、膨大な数の患者を追跡・監視するための高度なヘルスケア技術に対するニーズの高まりによるもので、低費用で質の高いヘルスケアに対する需要の高まりがこの市場の成長を後押ししています。

主な参加企業の内訳は以下の通りです：
- 企業タイプ別：Tier1：35％、Tier2：45％、Tier3：20
- 役職別 - Cレベル：31％、ディレクターレベル：27％、その他：42%
- 地域別：北米40％、欧州20％、アジア太平洋30％、中南米5％、中東＆アフリカ5

メタバース・イン・ヘルスケア市場の主要プレイヤー
メタバース・イン・ヘルスケア市場で事業を展開する主なプレーヤーは、Microsoft（米国）、NVIDIA Corporation（米国）、XRHealth（米国）、CAE, Inc.（カナダ）、Koninklijke Philips N.V. （オランダ）、 ImmersiveTouch, Inc（米国）、Wipro（インド）、Siemens Healthineers AG（ドイツ）、 Medtronic plc（アイルランド）、GEヘルスケア（米国）、 Intuitive Surgical （米国）、 8Chili、 Inc.(米国）、MindMaze（スイス）、AccuVein, Inc.（米国）、EON Reality（米国）、Brainlab AG（ドイツ）、Novarad Corporation（米国）、Oodles Technologies（インド）、CMR Surgical（英国）、Merative（米国）、BioflightVR（米国）、WorldViz社（米国）、Google（米国）、Oculus (Meta Platforms, Inc.)(US), Augmedics (US)
調査対象です：
当レポートでは、ヘルスケアにおけるメタバース市場を分析し、コンポーネント、アプリケーション、テクノロジー、エンドユーザー、地域に基づいて、様々な市場セグメントの市場規模および将来の成長可能性を推定することを目的としています。また、本市場で事業を展開する主要企業の競争分析も行い、企業プロフィール、製品提供、最近の開発状況、主要な市場戦略も併せて掲載しています。
本レポートを購入する理由
本レポートは、既存企業だけでなく、新規参入企業や小規模企業も市場の動向を把握するのに役立ち、ひいては市場シェアを拡大するのに役立ちます。本レポートは、市場全体とサブセグメントの売上高の最も近い近似値に関する情報を提供することで、この市場のリーダー/新規参入者に役立つことでしょう。本レポートは、関係者が競争環境を理解し、より多くの洞察を得ることで、自社のビジネスをより良く位置づけ、適切な市場参入を計画するのに役立つだろう。

本レポートは、以下のポイントに関する洞察を提供します：
- 主要な推進要因（低侵襲手術の実施に向けた複合現実の採用拡大、遠隔医療におけるメタバースの応用、デジタルツインの利用拡大、医療におけるブロックチェーン技術の重要性の高まり）の分析、阻害要因（データプライバシーとセキュリティの懸念、高い導入コスト、過度の使用による健康と精神の問題）、機会（医療教育とトレーニングにおけるメタバース利用の増加、外科手術アプリケーションにおけるメタバース利用）および課題（医療メタバースに対するHIPAA規制、相互運用性問題、環境影響と結合した地域政府の規制）。

- 製品開発/イノベーション：医療用メタバース市場における今後の技術、研究開発活動、新製品・サービス投入に関する詳細な洞察

- 市場開発：有利な市場に関する包括的な情報 - 本レポートでは、さまざまな地域の医療用メタバース市場を分析しています。

- 市場の多様化：新製品・サービス、未開拓の地域、最近の開発、メタバース・イン・ヘルスケア市場での投資に関する情報を網羅的に提供します。

- 競合他社の評価：Microsoft（米国）、NVIDIA Corporation（米国）、XRHealth（米国）、CAE, Inc.（カナダ）、Koninklijke Philips N.V. （オランダ）、ImmersiveTouch, Inc.(米国）、Wipro（インド）、Siemens Healthineers AG（ドイツ）、Medtronic plc（アイルランド）、GE Healthcare（米国）、Intuitive Surgical（米国）、8Chili、Inc（米国）、MindMaze（スイス）、AccuVein、Inc（米国）、EON Reality（米国）、Brainlab AG（ドイツ）、Novarad Corporation（米国）、Oodles Technologies（インド）などの医療市場におけるメタバース戦略で、特に、このレポートは、この市場においての利害関係者の理解を助けます。また、本レポートは、関係者がリモートケア市場の鼓動を理解するのに役立ち、主要な市場促進要因、阻害要因、課題、および機会に関する情報を提供します。

ページTOPに戻る

1 INTRODUCTION 26
1.1 STUDY OBJECTIVES 26
1.2 MARKET DEFINITION 26
1.2.1 INCLUSIONS AND EXCLUSIONS 27
1.3 MARKETS COVERED 27
1.3.1 METAVERSE IN HEALTHCARE MARKET SEGMENTATION, BY REGION 28
1.3.2 YEARS CONSIDERED 28
1.4 CURRENCY CONSIDERED 28
1.5 STAKEHOLDERS 29
1.6 LIMITATIONS 29
1.7 RECESSION IMPACT 29
2 RESEARCH METHODOLOGY 30
2.1 RESEARCH APPROACH 30
2.2 RESEARCH METHODOLOGY DESIGN 30
FIGURE 1 METAVERSE IN HEALTHCARE MARKET: RESEARCH DESIGN 30
2.2.1 SECONDARY RESEARCH 31
2.2.1.1 Key data from secondary sources 32
2.2.2 PRIMARY DATA 32
FIGURE 2 PRIMARY SOURCES 32
2.2.2.1 Key data from primary sources 33
2.2.2.2 Insights from primary experts 34
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY, DESIGNATION, AND REGION 34
2.3 MARKET SIZE ESTIMATION: METAVERSE IN HEALTHCARE MARKET 35
FIGURE 4 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 35
FIGURE 5 METAVERSE IN HEALTHCARE MARKET: TOP-DOWN AND BOTTOM-UP APPROACHES 36
2.3.1 DEMAND-SIDE APPROACH 37
FIGURE 6 MARKET PROJECTIONS FROM DEMAND-SIDE 37
FIGURE 7 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 38
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 39
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 40
2.5 MARKET RANKING ESTIMATION 41
2.6 ASSUMPTIONS 41
2.7 LIMITATIONS 42
2.7.1 METHODOLOGY-RELATED LIMITATIONS 42
2.7.2 SCOPE-RELATED LIMITATIONS 42
2.8 RISK ASSESSMENT 42
TABLE 1 RISK ASSESSMENT: METAVERSE IN HEALTHCARE MARKET 42
2.9 IMPACT OF RECESSION ON METAVERSE IN HEALTHCARE MARKET 42
3 EXECUTIVE SUMMARY 44
FIGURE 2 METAVERSE IN HEALTHCARE MARKET, BY COMPONENT, 2023 VS. 2028 (USD MILLION) 44
FIGURE 3 METAVERSE IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION) 45
FIGURE 4 METAVERSE IN HEALTHCARE MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 46
FIGURE 5 METAVERSE IN HEALTHCARE MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 46
FIGURE 6 GEOGRAPHICAL SNAPSHOT OF METAVERSE IN HEALTHCARE MARKET 47
4 PREMIUM INSIGHTS 49
4.1 METAVERSE IN HEALTHCARE MARKET OVERVIEW 49
FIGURE 7 INCREASING ADOPTION OF MIXED REALITY SOLUTIONS IN HEALTHCARE APPLICATIONS TO DRIVE MARKET GROWTH 49
4.2 ASIA PACIFIC: METAVERSE IN HEALTHCARE MARKET, BY COMPONENT AND COUNTRY 50
FIGURE 8 SOFTWARE SEGMENT TO COMMAND LARGEST SHARE OF ASIA PACIFIC MARKET IN 2023 50
4.3 GEOGRAPHICAL SNAPSHOT OF METAVERSE IN HEALTHCARE MARKET 51
FIGURE 9 MARKET IN CHINA TO GROW AT HIGHEST CAGR 51
4.4 REGIONAL MIX: METAVERSE IN HEALTHCARE MARKET 52
FIGURE 10 ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 52
4.5 METAVERSE IN HEALTHCARE MARKET: DEVELOPED VS. DEVELOPING MARKETS 52
FIGURE 11 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES 52
5 MARKET OVERVIEW 53
5.1 INTRODUCTION 53
5.2 MARKET DYNAMICS 53
TABLE 2 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: IMPACT ANALYSIS 53
5.2.1 DRIVERS 54
5.2.1.1 Increasing adoption of mixed reality for performing minimally invasive surgeries 54
5.2.1.2 Applications of metaverse in telemedicine 54
5.2.1.3 Increasing use of digital twins 55
5.2.1.4 Increasing importance of blockchain technology in healthcare 56
5.2.2 RESTRAINTS 57
5.2.2.1 Data privacy and security concerns 57
FIGURE 12 US: NUMBER OF DATA BREACHES (2005–2022) 58
5.2.2.2 High implementation cost 58
5.2.2.3 Health and mental issues from excessive use 58
5.2.3 OPPORTUNITIES 59
5.2.3.1 Increasing use of metaverse in medical education and training 59
5.2.3.2 Use of metaverse in surgical applications 60
5.2.4 CHALLENGES 60
5.2.4.1 HIPAA regulations for healthcare metaverse 60
5.2.4.2 Interoperability issues 61
5.2.4.3 Local government restrictions coupled with environmental impact 61
6 INDUSTRY INSIGHTS 62
6.1 INDUSTRY TRENDS 62
6.1.1 TRANSFORMATION IN CLINICAL TRIALS 62
6.1.2 EMERGENCE OF IMMERSIVE THERAPEUTICS 62
6.1.3 FUTURE TRENDS IN METAVERSE IN HEALTHCARE 62
6.2 RISE IN HEALTHCARE METAVERSE INVESTMENTS 63
6.3 TECHNOLOGY ANALYSIS 64
6.3.1 TECHNOLOGY STACK 64
FIGURE 13 METAVERSE MARKET: TECHNOLOGIES 64
6.3.2 INFRASTRUCTURE LEVEL 64
6.3.2.1 5G network 64
6.3.2.2 Internet of Things 65
6.3.2.3 Cloud and edge computing 65
6.3.3 DESIGN AND DEVELOPMENT LEVEL 65
6.3.3.1 Blockchain 65
6.3.3.2 3D modeling and real-time rendering 65
6.3.3.3 Artificial intelligence, natural language processing, and computer vision 66
6.3.4 HUMAN INTERACTION LEVEL 66
6.3.4.1 Virtual reality 66
6.3.4.2 Augmented reality 66
6.3.4.2.1 Monitor-based AR technology 67
6.3.4.2.2 Near-eye-based AR technology 67
6.3.4.2.3 Web AR 68
6.3.4.3 Mixed reality 68
6.4 PORTER’S FIVE FORCES ANALYSIS 68
FIGURE 14 METAVERSE IN HEALTHCARE MARKET: PORTER’S FIVE FORCES ANALYSIS 69
TABLE 3 METAVERSE IN HEALTHCARE MARKET: PORTER’S FIVE FORCES ANALYSIS 69
6.4.1 INTENSITY OF COMPETITIVE RIVALRY 70
6.4.2 BARGAINING POWER OF SUPPLIERS 70
6.4.3 BARGAINING POWER OF BUYERS 70
6.4.4 THREAT OF NEW ENTRANTS 71
6.4.5 THREAT OF SUBSTITUTES 71

6.5 REGULATORY LANDSCAPE 72
6.5.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 72
TABLE 4 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 72
TABLE 5 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73
TABLE 6 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74
TABLE 7 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 75
6.5.2 REGULATORY IMPLICATIONS AND INDUSTRY STANDARDS 77
6.6 VALUE-CHAIN ANALYSIS 77
FIGURE 15 VALUE-CHAIN ANALYSIS (2022) 78
6.7 ECOSYSTEM 78
FIGURE 16 METAVERSE IN HEALTHCARE MARKET: ECOSYSTEM 79
6.8 PATENT ANALYSIS 79
FIGURE 17 NUMBER OF PATENTS PUBLISHED, JANUARY 2013 TO MARCH 2023 79
FIGURE 18 TOP METAVERSE IN HEALTHCARE PATENT OWNERS 80
TABLE 8 KEY PATENTS IN THE METAVERSE IN HEALTHCARE MARKET 80
6.9 CASE STUDY ANALYSIS 81
6.9.1 CASE STUDY 1: RIGOROUS TRAINING OF PROFESSIONAL ATHLETES WITHOUT PHYSICAL STRAIN 81
6.9.2 CASE STUDY 2: AUGMENTED REALITY FOR SURGERY 82
6.9.3 CASE STUDY 3: VIRTUAL HOSPITALS AND CLINICS 82
6.9.4 CASE STUDY 4: ENTERING DRUG DISCOVERY AND RESEARCH 82
6.9.5 CASE STUDY 5: ENTERING MEDICAL TRAINING AND EDUCATION 83
6.10 KEY STAKEHOLDERS AND BUYING CRITERIA 83
6.10.1 KEY STAKEHOLDERS IN BUYING PROCESS 83
FIGURE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 83
TABLE 9 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%) 84
6.10.2 BUYING CRITERIA 84
FIGURE 20 KEY BUYING CRITERIA FOR METAVERSE COMPONENTS 84
TABLE 10 KEY BUYING CRITERIA FOR METAVERSE COMPONENTS 84
6.11 KEY CONFERENCES AND EVENTS IN 2023–2024 85
TABLE 11 METAVERSE IN HEALTHCARE MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 85
6.12 TRENDS/DISRUPTIONS IMPACTING BUYERS 86
FIGURE 21 METAVERSE MARKET: TRENDS/DISRUPTIONS IMPACTING BUYERS 86

7 METAVERSE IN HEALTHCARE MARKET, BY COMPONENT 87
7.1 INTRODUCTION 88
TABLE 12 METAVERSE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 88
TABLE 13 METAVERSE IN HEALTHCARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 88
7.2 SOFTWARE 89
7.2.1 INCREASING INVESTMENTS IN AR/VR TECHNOLOGY IN HEALTHCARE TO DRIVE GROWTH 89
TABLE 14 METAVERSE IN HEALTHCARE SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 90
7.3 HARDWARE 90
7.3.1 AR DEVICES 90
7.3.2 VR DEVICES 91
7.3.3 MR DEVICES 91
7.3.4 DISPLAYS 91
TABLE 15 METAVERSE IN HEALTHCARE HARDWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 92
7.4 SERVICES 92
7.4.1 SERVICES HELP IMPROVE PATIENT CARE, ENHANCE MEDICAL TRAINING AND EDUCATION, AND ENABLE REMOTE HEALTHCARE 92
TABLE 16 METAVERSE IN HEALTHCARE SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 93
8 METAVERSE IN HEALTHCARE MARKET, BY TECHNOLOGY 94
8.1 INTRODUCTION 95
TABLE 17 METAVERSE IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 95
8.2 AUGMENTED AND VIRTUAL REALITY 95
8.2.1 INCREASING DEMAND FOR AR/VR APPLICATIONS IN HEALTHCARE TO DRIVE GROWTH 95
TABLE 18 METAVERSE IN HEALTHCARE MARKET FOR AUGMENTED AND VIRTUAL REALITY, BY COUNTRY, 2021–2028 (USD MILLION) 96
8.3 MIXED REALITY 96
8.3.1 INCREASING AWARENESS OF DIGITAL/VIRTUAL MEDICINE TO DRIVE GROWTH 96
TABLE 19 METAVERSE IN HEALTHCARE MARKET FOR MIXED REALITY, BY COUNTRY, 2021–2028 (USD MILLION) 97
8.4 ARTIFICIAL INTELLIGENCE 97
8.4.1 WIDE AVAILABILITY OF COMPLEX DATASETS TO DRIVE GROWTH 97
TABLE 20 METAVERSE IN HEALTHCARE MARKET FOR ARTIFICIAL INTELLIGENCE, BY COUNTRY, 2021–2028 (USD MILLION) 98
8.5 BLOCKCHAIN 98
8.5.1 INCREASING NEED TO REDUCE COST OF SECURE DATA EXCHANGE TO DRIVE GROWTH 98
TABLE 21 METAVERSE IN HEALTHCARE MARKET FOR BLOCKCHAIN, BY COUNTRY, 2021–2028 (USD MILLION) 99
8.6 DIGITAL TWIN 99
8.6.1 INCREASING ADOPTION OF DIGITALIZATION IN HEALTHCARE TO PROPEL MARKET GROWTH 99
TABLE 22 DESCRIPTION OF DIGITAL TWIN IN HEALTHCARE CONTEXT 100
TABLE 23 METAVERSE IN HEALTHCARE MARKET FOR DIGITAL TWIN, BY COUNTRY, 2021–2028 (USD MILLION) 100
8.7 INTERNET OF THINGS 100
8.7.1 ADVANCEMENTS IN HEALTHCARE AND WIDE ACCEPTANCE OF REMOTE CARE TO DRIVE GROWTH 100
TABLE 24 METAVERSE IN HEALTHCARE MARKET FOR INTERNET OF THINGS, BY COUNTRY, 2021–2028 (USD MILLION) 101
8.8 MEDICAL WEARABLES 102
8.8.1 INCREASING FOCUS ON FITNESS AND HEALTH TO SUPPORT GROWTH 102
TABLE 25 METAVERSE IN HEALTHCARE MARKET FOR MEDICAL WEARABLES, BY COUNTRY, 2021–2028 (USD MILLION) 102
9 METAVERSE IN HEALTHCARE MARKET, BY APPLICATION 103
9.1 INTRODUCTION 104
TABLE 26 METAVERSE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 104
9.2 DIGITAL THERAPEUTICS 104
9.2.1 RISING INCIDENCE OF PREVENTABLE CHRONIC DISEASES TO DRIVE GROWTH 104
TABLE 27 METAVERSE IN HEALTHCARE MARKET FOR DIGITAL THERAPEUTICS, BY COUNTRY, 2021–2028 (USD MILLION) 105
9.3 MEDICAL DIAGNOSTICS 105
9.3.1 METAVERSE ENVIRONMENT CAN OFFER ENHANCED MEDICAL DIAGNOSTICS 105
TABLE 28 METAVERSE IN HEALTHCARE MARKET FOR MEDICAL DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION) 106
9.4 MEDICAL EDUCATION AND SURGICAL TRAINING 106
9.4.1 METAVERSE ADDING NEW DIMENSIONS TO MEDICAL EDUCATION AND SURGICAL TRAINING 106
TABLE 29 METAVERSE IN HEALTHCARE MARKET FOR MEDICAL EDUCATION AND SURGICAL TRAINING, BY COUNTRY, 2021–2028 (USD MILLION) 107
9.5 TELEHEALTH AND TELEMEDICINE 107
9.5.1 GROWING GERIATRIC POPULATION TO DRIVE MARKET GROWTH 107
TABLE 30 METAVERSE IN HEALTHCARE MARKET FOR TELEHEALTH AND TELEMEDICINE, BY COUNTRY, 2021–2028 (USD MILLION) 108
9.6 DRUG DISCOVERY AND PERSONALIZED MEDICINE 109
9.6.1 METAVERSE TO HELP REDUCE TIME AND COST INVOLVED IN DRUG DISCOVERY 109
TABLE 31 METAVERSE IN HEALTHCARE MARKET FOR DRUG DISCOVERY AND PERSONALIZED MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION) 110
9.7 OTHER APPLICATIONS 110
TABLE 32 METAVERSE IN HEALTHCARE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 111
10 METAVERSE IN HEALTHCARE MARKET, BY END USER 112
10.1 INTRODUCTION 113
TABLE 33 METAVERSE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 113
10.2 HEALTHCARE PROVIDERS 113
10.2.1 INCREASING NEED TO IMPROVE PROFITABILITY OF HEALTHCARE OPERATIONS TO BOOST GROWTH 113
TABLE 34 METAVERSE IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION) 114
10.3 HEALTHCARE PAYERS 114
10.3.1 INCREASING FOCUS ON OUTCOME-BASED PAYMENT MODELS TO DRIVE DEMAND 114
TABLE 35 METAVERSE IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY COUNTRY, 2021–2028 (USD MILLION) 115
10.4 PHARMACEUTICAL, BIOPHARMACEUTICAL, AND MEDTECH COMPANIES 115
10.4.1 ENHANCED CLINICAL TRIALS AND BETTER COLLABORATION AND COMMUNICATION TO DRIVE GROWTH 115
TABLE 36 METAVERSE IN HEALTHCARE MARKET FOR PHARMACEUTICAL, BIOPHARMACEUTICAL, AND MEDTECH COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 116
10.5 PATIENTS 117
10.5.1 INCREASED ACCESS TO CARE AND IMPROVED PATIENT OUTCOMES TO SUPPORT MARKET GROWTH 117
TABLE 37 METAVERSE IN HEALTHCARE MARKET FOR PATIENTS, BY COUNTRY, 2021–2028 (USD MILLION) 117
10.6 OTHER END USERS 118
TABLE 38 METAVERSE IN HEALTHCARE MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 119
11 METAVERSE IN HEALTHCARE MARKET, BY REGION 120
11.1 INTRODUCTION 121
TABLE 39 METAVERSE IN HEALTHCARE MARKET, BY REGION, 2021–2028 (USD MILLION) 121
11.2 NORTH AMERICA 121
11.2.1 NORTH AMERICA: IMPACT OF RECESSION ON METAVERSE IN HEALTHCARE MARKET 121
FIGURE 22 NORTH AMERICA: METAVERSE IN HEALTHCARE MARKET SNAPSHOT 122
TABLE 40 NORTH AMERICA: METAVERSE IN HEALTHCARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 41 NORTH AMERICA: METAVERSE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 123
TABLE 42 NORTH AMERICA: METAVERSE IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 124
TABLE 43 NORTH AMERICA: METAVERSE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 124
TABLE 44 NORTH AMERICA: METAVERSE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 125
11.2.2 US 125
11.2.2.1 Increasing adoption of healthcare technologies to drive growth 125
TABLE 45 US: METAVERSE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 125
TABLE 46 US: METAVERSE IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 126
TABLE 47 US: METAVERSE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 126
TABLE 48 US: METAVERSE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 127
11.2.3 CANADA 127
11.2.3.1 Increasing focus on patient-centric care to support growth 127
TABLE 49 CANADA: METAVERSE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 128
TABLE 50 CANADA: METAVERSE IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 128
TABLE 51 CANADA: METAVERSE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 129
TABLE 52 CANADA: METAVERSE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 129
11.3 EUROPE 130
11.3.1 EUROPE: IMPACT OF RECESSION ON METAVERSE IN HEALTHCARE MARKET 130
TABLE 53 EUROPE: METAVERSE IN HEALTHCARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 130
TABLE 54 EUROPE: METAVERSE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 131
TABLE 55 EUROPE: METAVERSE IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 131
TABLE 56 EUROPE: METAVERSE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 132
TABLE 57 EUROPE: METAVERSE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 132
11.3.2 UK 133
11.3.2.1 Recent technological advancements and focus on better patient outcomes to drive growth 133
TABLE 58 UK: METAVERSE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 133
TABLE 59 UK: METAVERSE IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 134
TABLE 60 UK: METAVERSE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 134
TABLE 61 UK: METAVERSE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 135
11.3.3 GERMANY 135
11.3.3.1 Increasing number of AR/VR start-ups to boost growth 135
TABLE 62 GERMANY: METAVERSE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 136
TABLE 63 GERMANY: METAVERSE IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 136
TABLE 64 GERMANY: METAVERSE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 137
TABLE 65 GERMANY: METAVERSE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 137
11.3.4 REST OF EUROPE 137
TABLE 66 REST OF EUROPE: METAVERSE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 138
TABLE 67 REST OF EUROPE: METAVERSE IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 138
TABLE 68 REST OF EUROPE: METAVERSE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 139
TABLE 69 REST OF EUROPE: METAVERSE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 139
11.4 ASIA PACIFIC 140
11.4.1 ASIA PACIFIC: IMPACT OF RECESSION ON METAVERSE IN HEALTHCARE MARKET 140
FIGURE 23 ASIA PACIFIC: METAVERSE IN HEALTHCARE MARKET SNAPSHOT 141
TABLE 70 ASIA PACIFIC: METAVERSE IN HEALTHCARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 142
TABLE 71 ASIA PACIFIC: METAVERSE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 142
TABLE 72 ASIA PACIFIC: METAVERSE IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 143
TABLE 73 ASIA PACIFIC: METAVERSE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 143
TABLE 74 ASIA PACIFIC: METAVERSE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 144
11.4.2 CHINA 144
11.4.2.1 Presence of large consumer base and increasing demand for quality healthcare to boost growth 144
TABLE 75 CHINA: METAVERSE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 145
TABLE 76 CHINA: METAVERSE IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 145
TABLE 77 CHINA: METAVERSE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 146
TABLE 78 CHINA: METAVERSE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 146
11.4.3 JAPAN 146
11.4.3.1 Adoption of wireless technology and government support to drive growth 146
TABLE 79 JAPAN: METAVERSE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 147
TABLE 80 JAPAN: METAVERSE IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 147
TABLE 81 JAPAN: METAVERSE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 148
TABLE 82 JAPAN: METAVERSE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 148
11.4.4 REST OF ASIA PACIFIC 149
TABLE 83 REST OF ASIA PACIFIC: METAVERSE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 149
TABLE 84 REST OF ASIA PACIFIC: METAVERSE IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 150
TABLE 85 REST OF ASIA PACIFIC: METAVERSE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 150
TABLE 86 REST OF ASIA PACIFIC: METAVERSE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 151
11.5 LATIN AMERICA 151
11.5.1 LATIN AMERICA: IMPACT OF RECESSION ON METAVERSE IN HEALTHCARE MARKET 151
TABLE 87 LATIN AMERICA: METAVERSE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 152
TABLE 88 LATIN AMERICA: METAVERSE IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 152
TABLE 89 LATIN AMERICA: METAVERSE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 153
TABLE 90 LATIN AMERICA: METAVERSE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 153
11.6 MIDDLE EAST AND AFRICA 154
11.6.1 INVESTMENTS IN DIGITAL TECHNOLOGIES TO SUPPORT GROWTH 154
11.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT ON METAVERSE IN HEALTHCARE MARKET 154
TABLE 91 MIDDLE EAST & AFRICA: METAVERSE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 155
TABLE 92 MIDDLE EAST & AFRICA: METAVERSE IN HEALTHCARE MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 155
TABLE 93 MIDDLE EAST & AFRICA: METAVERSE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 156
TABLE 94 MIDDLE EAST & AFRICA: METAVERSE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 156
12 COMPETITIVE LANDSCAPE 157
12.1 OVERVIEW 157
12.2 KEY STRATEGIES/RIGHT TO WIN 157
TABLE 95 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN METAVERSE IN HEALTHCARE MARKET 157
FIGURE 24 KEY DEVELOPMENTS OF MAJOR PLAYERS BETWEEN JANUARY 2020 AND MARCH 2023 160
12.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 161
FIGURE 25 METAVERSE IN HEALTHCARE MARKET: REVENUE SHARE ANALYSIS OF KEY PLAYERS 161
12.4 METAVERSE IN HEALTHCARE MARKET: R&D EXPENDITURE 161
FIGURE 26 R&D EXPENDITURE OF KEY PLAYERS (2021 VS. 2022) 161
12.5 MARKET RANKING ANALYSIS 162
FIGURE 27 METAVERSE IN HEALTHCARE MARKET RANKING ANALYSIS OF KEY PLAYERS (2022) 162
12.6 COMPETITIVE BENCHMARKING 164
TABLE 96 FOOTPRINT OF COMPANIES IN METAVERSE IN HEALTHCARE MARKET 164
TABLE 97 PRODUCT/SERVICE FOOTPRINT OF COMPANIES (25 COMPANIES) 165
TABLE 98 TECHNOLOGY FOOTPRINT OF COMPANIES (25 COMPANIES) 166
TABLE 99 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES) 167
12.7 COMPANY EVALUATION MATRIX 168
12.7.1 STARS 168
12.7.2 EMERGING LEADERS 168
12.7.3 PERVASIVE PLAYERS 168
12.7.4 PARTICIPANTS 168
FIGURE 28 METAVERSE IN HEALTHCARE MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022) 169
12.8 COMPANY EVALUATION MATRIX FOR START-UPS/SMES 169
12.8.1 PROGRESSIVE COMPANIES 169
12.8.2 DYNAMIC COMPANIES 170
12.8.3 RESPONSIVE COMPANIES 170
12.8.4 STARTING BLOCKS 170
FIGURE 29 METAVERSE IN HEALTHCARE MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022) 170
12.9 COMPETITIVE SCENARIO 171
12.9.1 PRODUCT/SERVICE LAUNCHES & APPROVALS 171
TABLE 100 PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2020–MARCH 2023 171
12.9.2 DEALS 172
TABLE 101 DEALS, JANUARY 2020–MARCH 2023 172
13 COMPANY PROFILES 173
13.1 KEY PLAYERS 173
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
13.1.1 MICROSOFT 173
TABLE 102 MICROSOFT: BUSINESS OVERVIEW 173
FIGURE 30 MICROSOFT: COMPANY SNAPSHOT (2022) 174
13.1.2 NVIDIA CORPORATION 177
TABLE 103 NVIDIA CORPORATION: BUSINESS OVERVIEW 177
FIGURE 31 NVIDIA CORPORATION: COMPANY SNAPSHOT (2022) 178
13.1.3 KONINKLIJKE PHILIPS N.V. 182
TABLE 104 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW 182
FIGURE 32 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022) 183
13.1.4 CAE INC. 186
TABLE 105 CAE INC.: BUSINESS OVERVIEW 186
FIGURE 33 CAE INC.: COMPANY SNAPSHOT (2022) 187
13.1.5 XRHEALTH 189
TABLE 106 XRHEALTH: BUSINESS OVERVIEW 189
13.1.6 IMMERSIVETOUCH, INC. 191
TABLE 107 IMMERSIVETOUCH, INC.: BUSINESS OVERVIEW 191
13.1.7 WIPRO 193
TABLE 108 WIPRO: BUSINESS OVERVIEW 193
FIGURE 34 WIPRO: COMPANY SNAPSHOT (2022) 194
13.1.8 SIEMENS HEALTHINEERS AG 196
TABLE 109 SIEMENS HEALTHINEERS AG: BUSINESS OVERVIEW 196
FIGURE 35 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2022) 197
13.1.9 MEDTRONIC PLC 199
TABLE 110 MEDTRONIC PLC: BUSINESS OVERVIEW 199
FIGURE 36 MEDTRONIC PLC: COMPANY SNAPSHOT (2022) 200
13.1.10 GE HEALTHCARE 202
TABLE 111 GE HEALTHCARE: BUSINESS OVERVIEW 202
FIGURE 37 GE HEALTHCARE: COMPANY SNAPSHOT (2022) 203
13.1.11 INTUITIVE SURGICAL, INC. 205
TABLE 112 INTUITIVE SURGICAL, INC.: BUSINESS OVERVIEW 205
FIGURE 38 INTUITIVE SURGICAL, INC.: COMPANY SNAPSHOT (2022) 206
13.1.12 BRAINLAB AG 208
TABLE 113 BRAINLAB AG: BUSINESS OVERVIEW 208
13.1.13 NOVARAD CORPORATION 211
TABLE 114 NOVARAD CORPORATION: COMPANY OVERVIEW 211
13.1.14 OODLES TECHNOLOGIES 213
TABLE 115 OODLES TECHNOLOGIES: COMPANY OVERVIEW 213
13.1.15 CMR SURGICAL 214
TABLE 116 CMR SURGICAL: COMPANY OVERVIEW 214
13.1.16 MERATIVE 217
TABLE 117 MERATIVE: COMPANY OVERVIEW 217
13.1.17 WORLDVIZ, INC. 219
TABLE 118 WORLDVIZ, INC.: BUSINESS OVERVIEW 219
13.1.18 GOOGLE 220
TABLE 119 GOOGLE: BUSINESS OVERVIEW 220
FIGURE 39 GOOGLE: COMPANY SNAPSHOT (2022) 221
13.1.19 OCULUS (META PLATFORMS) 223
TABLE 120 OCULUS (META PLATFORMS): BUSINESS OVERVIEW 223
13.1.20 MINDMAZE 225
TABLE 121 MINDMAZE: BUSINESS OVERVIEW 225

13.2 OTHER PLAYERS 227
13.2.1 AUGMEDICS 227
13.2.2 ACCUVEIN, INC. 227
13.2.3 EON REALITY 228
13.2.4 BIOFLIGHTVR 228
13.2.5 8CHILI, INC. 229
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
14 APPENDIX 230
14.1 DISCUSSION GUIDE 230
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 234
14.3 CUSTOMIZATION OPTIONS 236
14.4 RELATED REPORTS 236
14.5 AUTHOR DETAILS 237

ページTOPに戻る

Table of Contents

Summary

The global metaverse in healthcare market is projected to reach USD 79.6 billion by 2028 from USD 9.5 billion in 2023, at a CAGR of 52.9% during the forecast period. There is a growing inclination for metaverse technologies for healthcare in North America. Increasing popularity of virtual and augmented reality (VR/AR) technologies, which have been used in various healthcare applications, including surgical training, pain management, and therapy is attributing to growth of the market in this region. In addition, the COVID-19 pandemic has accelerated the adoption of telehealth services, which has created a need for more immersive and engaging virtual experiences for patients and healthcare providers. The metaverse can provide a virtual environment that simulates real-life interactions, allowing patients and healthcare professionals to communicate and collaborate in a more natural and intuitive way.

“The software segment is projected to be the largest segment in the metaverse in healthcare market”.
Based on the components, the software segment is projected to be the largest segment during the forecast period. This share can be attributed to factors such as potential for customization and personalization. Healthcare professionals and patients can use software to create and access virtual environments that are tailored to their specific needs, preferences, and medical conditions, increasing adaptation of AR platforms to perform complex surgical procedures for higher precision and flexibility and investments made in the software segment.

“Healthcare Provider was the largest segment by the end user of metaverse in healthcare market in 2022”.
Healthcare provider is projected to grow at the highest growth rate in the metaverse in healthcare market in 2022. The high growth can be attributed to rising need for an efficient healthcare system, growing patient volume, increasing number of hospitals and ambulatory care centers, growth in telehealth and rising adoption of metaverse technology in healthcare.

“APAC to witness the highest growth rate during the forecast period.”
The Asia Pacific market is projected to grow at the highest CAGR during the forecast period. Market growth in the APAC region is mainly driven by factors owing to the growing medical tourism industry, increasing incidence of lifestyle and chronic disorders, and the rising adoption of metaverse technologies. Asia Pacific market offer lucrative growth opportunities for market players, mainly due to the growing government initiatives and the increasing incidence of lifestyle disorders. The growth in these markets will likely be centered in China, South Korea, and Japan. This is mainly due to the rising need for advanced healthcare technology to track and monitor the huge volume of patients, and the rising demand for quality healthcare at low costs are driving the growth of this market.

The break-down of primary participants is as mentioned below:
• By Company Type - Tier 1: 35%, Tier 2: 45%, and Tier 3: 20%
• By Designation - C-level: 31%, Director-level: 27%, and Others: 42%
• By Region - North America: 40%, Europe: 20%, Asia Pacific: 30%, Latin America: 5%, and Middle East & Africa: 5%.

Key players in the Metaverse in Healthcare Market
The key players operating in the metaverse in healthcare market include Microsoft (US), NVIDIA Corporation (US), XRHealth (US), CAE, Inc.(Canada), Koninklijke Philips N.V. (Netherlands), ImmersiveTouch, Inc. (US), Wipro (India), Siemens Healthineers AG (Germany), Medtronic plc(Ireland), GE Healthcare(US), Intuitive Surgical (US), 8Chili, Inc. (US), MindMaze (Switzerland), AccuVein, Inc.(US),EON Reality(US), Brainlab AG (Germany), Novarad Corporation (US), Oodles Technologies (India), CMR Surgical(UK), Merative (US), BioflightVR(US), WorldViz, Inc. (US), Google(US), Oculus(Meta Platforms, Inc.)(US), Augmedics(US)
Research Coverage:
The report analyses the metaverse in healthcare market and aims to estimate the market size and future growth potential of various market segments, based on components, application, technology, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market.

The report provides insights on the following pointers:
• Analysis of key drivers (Increasing adoption of mixed reality for performing minimally invasive surgeries, Applications of metaverse in telemedicine, Increasing use of digital twins, Increasing importance of blockchain technology in healthcare) restraints (Data privacy and security concerns, High implementation cost, Health and mental issues from excessive use), opportunities (increasing use of metaverse in medical education and training and use of metaverse in surgical applications) and challenges ( HIPAA regulations for healthcare metaverse, Interoperability issues, Local government restrictions coupled with environmental impact)

• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the metaverse in healthcare market

• Market Development: Comprehensive information about lucrative markets – the report analyses the metaverse in healthcare market across varied regions.

• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the metaverse in healthcare market

• Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like Microsoft (US), NVIDIA Corporation (US), XRHealth (US), CAE, Inc.(Canada), Koninklijke Philips N.V. (Netherlands), ImmersiveTouch, Inc. (US), Wipro (India), Siemens Healthineers AG (Germany), Medtronic plc(Ireland), GE Healthcare(US), Intuitive Surgical (US), 8Chili, Inc. (US), MindMaze (Switzerland), AccuVein, Inc.(US),EON Reality(US), Brainlab AG (Germany), Novarad Corporation (US), Oodles Technologies (India), among others in the metaverse in healthcare market strategies. The report also helps stakeholders understand the pulse of the remote care market and provides them information on key market drivers, restraints, challenges, and opportunities.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

本レポートと同分野の最新刊レポートはありません。

MarketsandMarkets社のHealthcare IT分野での最新刊レポート

本レポートと同じKEY WORD（blockchain）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野の最新刊レポート

MarketsandMarkets社のHealthcare IT分野での最新刊レポート

本レポートと同じKEY WORD（blockchain）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?